The Valeda LDS treatment for dry AMD is now FDA approved

By adminjohnrose | November 9, 2024 |

LumiThera has received U.S. FDA authorisation to market its Valeda® Light Delivery System, the first FDA-approved treatment for vision loss due to dry age-related macular degeneration (AMD). The non-invasive photobiomodulation (PBM) device demonstrated improved visual acuity and safety over 24 months in the pivotal LIGHTSITE III trial, with results showing that Valeda slowed disease progression…

Read More